A tiny GLP-1 implant is the latest bet to help patients maintain their weight loss

Vivani Medical is developing an implant containing semaglutide, the active ingredient in Novo Nordisk's obesity treatment Wegovy and diabetes drug Ozempic, as a new approach to help patients maintain weight loss.